Fox Chase Cancer Center and Temple Health Present Research at the American Urological Association 2023 Annual Meeting

AUA
Fox Chase Cancer Center and Temple Health researchers will participate in the presentation and discussion of 24 research projects at the American Urological Association 2023 Annual Meeting.

PHILADELPHIA (April 28, 2023)—Fox Chase Cancer Center and Temple Health researchers will participate in the presentation and discussion of 24 research projects at the American Urological Association (AUA) 2023 Annual Meeting, which is being held in Chicago April 28-May 1. An asterisk (*) indicates that the author is the main presenter.

Friday, April 28

V01-07: Decision Point for Buccal Mucosa Graft Ureteroplasty: Augmented Anastomotic versus Ventral Onlay Technique; Matthew Lee*, Temple University; David Strauss, Temple Health; Julienne Jeong, Columbia University; Jeffrey Wei, Community Memorial Hospital; Joshua Kim, Florida State University College of Medicine; Ziho Lee, Northwestern University Feinberg School of Medicine; Lee Zhao, NYU Langone Medical Center; Michael Stifelman, Hackensack University Medical Center; Daniel Eun, MD Lewis Katz School of Medicine at Temple University; Friday, April 28, 2023 8:00 AM – 8:10 AM CST; Location: Video Abstract Theater.

V03-07: Robotic Inferior Vena Cava Grafting and Reconstruction; Matthew Lee*, Temple University; Aeen Asghar, The Permanente Medical Group Inc.; David Strauss, Temple Health; Naveen Krishnan, Indiana University Health; Daniel Eun, MD, Lewis Katz School of Medicine at Temple University; Friday, April 28, 2023 1:50 PM – 2:00 PM CST; Location: Video Abstract Theater.

MP22-14: LAG3 Expression Associated with Survival in Patients with Bladder Cancer; Tamir Sholklapper*, Einstein Healthcare Network; Laura Bukavina, Fox Chase Cancer Center; Andres Correa, MD, Fox Chase Cancer Center; Alexander Kutikov, MD, FACS, Fox Chase Cancer Center; Philip Abbosh, MD, PhD, Fox Chase Cancer Center; Friday, April 28, 2023 3:30 PM – 5:30 PM CST; Location: S405.

MP10-06: Risk Factors for Nephrolithiasis in 24-Hour Urine Studies of Patients with Nonalcoholic Fatty Liver Disease (NAFLD); Michelle Chen*, Einstein Healthcare Network; Alex Nourian, Einstein Healthcare Network; Johnathan Drevik, Einstein Healthcare Network; Eric Ghiraldi, DO, Fox Chase Cancer Center; Justin Friedlander, MD, Fox Chase Cancer Center; Friday, April 28, 2023 9:30 AM – 11:30 AM CST; Location: S405.

MP15-15: Comparing Infectious Complications in Patients Undergoing Transperineal Biopsy with and Without Antibiotic Prophylaxis; Olutiwa Akinsola, Vanderbilt University Medical Center; Spencer Bell*, Fox Chase Cancer Center; David Feng, Center for Vein Restoration; Andres Correa, MD, Fox Chase Cancer Center; Kristen Scarpato, Vanderbilt University Medical Center; Friday, April 28, 2023 1:00 PM – 3:00 PM CST; Location: S404C.

Crossfire: Controversies in Urology: Thermal Ablation vs. partial nephrectomy for a 3 cm renal mass in 49-year-old male
Friday, April 28, 2023, 1:25 PM – 1:55 PM CST. Location: Hall B1.
Moderator(s) Peter Anthony Pinto, MD, National Cancer Institute, National Institutes of Health
Debater(s) Jeffrey Anthony Cadeddu, MD, Professor, UT Southwestern Medical Center Ithaar H. Derweesh, MD, Professor of Urology and Radiology, University of California San Diego School of Medicine Robert G. Uzzo, MD, MBA, FACS, President and CEO, Fox Chase Cancer Center, Fox Chase Cancer Center - Temple University Health System Alexander Kutikov, MD, FACS, Chief, Urology and Urologic Oncology, Fox Chase Cancer Center

7th Annual Innovations in Robotic Surgery – Videos in 3D
Friday, April 28, 2023 5:30 PM – 7:30 PM CST Location: S100BC
Co-Course Director(s) Ashutosh Kumar Tewari, MD, MBBS, Chair, Department of Urology, Icahn School of Medicine at Mount Sinai Ketan Badani, MD, Vice Chair, Department of Urology and Director of Robotic Operations, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai Hospital Peter Wiklund, MD, PhD, Director of Bladder Cancer Program, Icahn School of Medicine at Mount Sinai Panelist(s) Alberto Breda, MD Fundacio Puigvert Francesco Montorsi, MD, Vita Salute San Raffaele University, Milan, Italy Kirsten Lynn Greene, MD, FACS, MS, Professor and Chair Francesco Porpiglia, MD, Full Professor of Urology, University of Turin Prokar Dasgupta, MD, King’s College London Andrea Minervini, MD Anant Kumar, MD, Max Superspeciality Hospital, Saket, New Delhi Nina Harke, MD Ashok Kumar Hemal, MD, FRCS, BS, Wake Forest School of Medicine Reza Mehrazin, MD, Mount Sinai Hospital John Sfakianos, MD, Rene Javier Sotelo, MD, Professor, University of Southern California Mutahar Ahmed, MD, Hackensack Meridian School of Medicine Jihad H. Kaouk, MD, FACS, FRCS, Professor of Surgery, Director Center for Robotic and Image Guided Surgery, Glickman Urologic Institute, Cleveland Clinic Alexander Kutikov, MD, FACS, Chief, Urology and Urologic Oncology, Fox Chase Cancer Center Riccardo Bertolo, MD, PHD

003IC - Robotic Upper Urinary Tract Reconstruction: A Top-to-Bottom Approach
Friday, April 28, 2023 7:30 AM – 9:30 AM CST Location: S103B
Instructional Course Director(s) Lee Cheng Zhao, MD, New York University School of Medicine Instructional Course
Faculty(s) Daniel Eun, MD, Professor of Urology, Lewis Katz School of Medicine at Temple University Michael D. Stifelman, MD Raju Thomas, MD, FACS, FRCS, Department Head, Tulane University

Panel with Challenging Cases
Friday, April 28, 2023 3:10 PM – 3:25 PM CST Location: S406A
Moderator(s) Maria Francesca Monn, MD, MPH, Southern Illinois University School of Medicine
Panelist(s) Jay Simhan, MD, FACS, Vice Chair, Department of Urology, Director of Reconstruction and Prosthetics, Fox Chase Cancer Center Paul J. Rusilko, DO, DO, FACS, University of Pittsburgh Medical Center UPMC Bradley Allan Erickson, MD, MS, Professor, University of Iowa

Saturday, April 29

PD15-10: Outcomes for Patients undergoing SpaceOAR Placement in the Salvage Radiation Therapy Setting; Spencer H. Bell*, Fox Chase Cancer Center; Emma Helstrom, Temple University; Eric M. Horwitz, MD, FABS, FASTRO, Fox Chase Cancer Center; Mark A. Hallman, MD, PhD, Fox Chase Cancer Center; Jessica Wong, MD, MEng, Fox Chase Cancer Center; Robert Uzzo, MD, MBA, FACS, Fox Chase Cancer Center; Alexander Kutikov, MD, FACS, Fox Chase Cancer Center; David Chen, MD, FACS, Fox Chase Cancer Center; Richard E. Greenberg, MD, FACS, Fox Chase Cancer Center; Marc C. Smaldone, MD, MSHP, FACS, Fox Chase Cancer Center; Rosalia Viterbo, MD, FACS,  Fox Chase Cancer Center; Nicole Uzzo, Temple University; Andres Correa, MD, Fox Chase Cancer Center, Saturday, April 29, 2023 8:30 AM – 8:40 AM CST; Location: S502.

MP39-17: Sequential intravesical gemcitabine-docetaxel versus bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: a preliminary cost-effectiveness analysis; Diana Magee*, Fox Chase Cancer Center; Laura Bukavina, Fox Chase Cancer Center; Spencer Bell, Fox Chase Cancer Center; Vignesh Packiam, University of Iowa Health Care; Marc Smaldone, MD, MSHP, FACS, Fox Chase Cancer Center; Phillip Abosh, MD, PhD, Fox Chase Cancer Center; Robert Uzzo, MD, MBA, FACS, Fox Chase Cancer Center; Alexander Kutikov, MD, FACS, Fox Chase Cancer Center; Andres Correa, MD, Fox Chase Cancer Center; Saturday, April 29, 2023 1:00 PM – 3:00 PM CST; Location: S404C.

MP42-13: Robotic Non-transecting Ureteral Reimplantation: A Multi-Institutional Experience; Brian Wen Chao*, NYU Langone Health; David Strauss, Temple Health; Matthew Lee, Temple University; Teona Iarajuli, Hackensack University Medical Center; Jennifer Nguyen, Southeast Texas Urology Assoc.; Ashley Alford, University of Minnesota; Michael Stifelman, Hackensack University Medical Center; Daniel Eun, MD, Lewis Katz School of Medicine at Temple University; Lee Zhao, NYU Langone Medical Center; Saturday, April 29, 2023 1:00 PM – 3:00 PM CST; Location: S505.

MP39-16: Cost-effectiveness analysis of universal CT staging versus selective CT staging strategies for patients with cT1a renal masses; Diana Magee*, Fox Chase Cancer Center; Kevin Ginsburg, Fox Chase Cancer Center; Jared Schober, Fox Chase Cancer Center; Laura Bukavina, Fox Chase Cancer Center; Spencer Bell, Fox Chase Cancer Center; Elizabeth Handorf, Fox Chase Cancer Center; Alexander Kutikov, MD, FACS, Fox Chase Cancer Center; Robert Uzzo, MD, MBA, FACS, Fox Chase Cancer Center; Andres Correa, MD, Fox Chase Cancer Center; Saturday, April 29, 2023 1:00 PM – 3:00 PM CST; Location: S404C.

MP47-13: A Comparative Analysis of Robot-assisted Retroperitoneoscopic Partial nephrectomy (RARPN) for Anterior vs Posterior Renal tumors: A Propensity Score Matched Analysis in a Multi-Institutional Cohort; Onika DV Noel*, UT San Antonio; Harshit Garg, UT Texas San Antonio; Kennedy Okhawere, Icahn School of Medicine at Mount Sinai; Mukuland Bhandari, San Antonio, TX; Indu Sinai, Cedars Sinai; Laura Zuluaga, Icahn School of Medicine at Mount Sinai; Ronney Abaza, Dublin, OH; Daniel Eun, MD, Lewis Katz School of Medicine at Temple University; Akshay Bhandari, Mount Sinai Medical Center; Ashok K. Hemal, Atrium Health Wake Forest Baptist; James Porter, Providence St. Joseph Health; Michael D. Stifelman, Hackensack University Medical Center; Jihad Kaouk, Cleveland Clinic; Simone Crivellaro, UI Health; Craig Rogers, Henry Ford Hospital; Philip Pierorazio, Hospital of the University of Pennsylvania; Ketan K. Badani, Icahn School of Medicine at Mount Sinai; Ahmed Mansour, University Health System; Saturday, April 29, 2023 3:30 PM – 5:30 PM CST; Location: S504.

Surgical Complications after Robotic Partial Nephrectomy
Saturday, April 29, 2023 1:30 PM – 1:40 PM CST Location: S105B
Alexander Kutikov, MD, FACS, Chief, Urology and Urologic Oncology, Fox Chase Cancer Center

MP47: Kidney Cancer: Localized: Surgical Therapy II
Saturday, April 29, 2023 3:30 PM – 5:30 PM CST Location: S504
CE: 1 Poster Session Moderator(s) Steven Charles Campbell, MD, PHD, Cleveland Clinic Ashok Kumar Hemal, MD, FRCS, BS, Wake Forest School of Medicine Alexander Kutikov, MD, FACS, Chief, Urology and Urologic Oncology, Fox Chase Cancer Center

Sunday, April 30

PD25-01: Macrophage Transcriptomic Signature Validation in scRNA Seq and Overall Survival Differences in Urothelial Carcinoma. Laura Bukavina*, Fox Chase Cancer Center; Imran Safder, Mamji Hospital; Spencer Bell, Fox Chase Cancer Center; Daniel Geynisman, MD, Fox Chase Cancer Center; Ilaha Isali, Case Western Reserve University; Daniel Ranti, Icahn School of Medicine at Mount Sinai; John Sfakianos, Icahn School of Medicine at Mount Sinai; Henkel Valentine, Fox Chase Cancer Center; Adam Calaway, UH Cleveland Medical Center; Alexander Kutikov, MD, FACS, Fox Chase Cancer Center; Andres Correa, MD, Fox Chase Cancer Center; Robert Uzzo, MD, MBA, FACS, Fox Chase Cancer Center; Lee Ponsky, UH Cleveland Medical Center; Philip Abbosh, MD, PhD, Fox Chase Cancer Center; Sunday, April 30, 2023, 7-7:10 a.m. CST. Location: S404A.

PD25-12: Identification of Intratumor Pathogens from Single-Cell RNA Sequencing, Cellular Dysfunction, and Immune Response. Laura Bukavina*, Fox Chase Cancer Center; Mohit Sindhani, Delhi, India; Henkel Valentine, Fox Chase Cancer Center; Daniel Ranti, Icahn School of Medicine at Mount Sinai; Kirtishri Mishra, University Hospitals of Cleveland; Alexander Kutikov, Fox Chase Cancer Center; Shilpa Gupta, Cleveland Clinic; John Sfakianos, Icahn School of Medicine at Mount Sinai; Mahmoud Ghannoum, Case Western Reserve University; Mauricio Retuerto, Case Western Reserve University; Andres Correa, MD, Fox Chase Cancer Center; Robert Uzzo, MD, MBA, FACS, Fox Chase Cancer Center; Philip Abbosh, MD, PhD, Fox Chase Cancer Center; Sunday, April 30, 2023, 8:50-9 a.m. CST. Location: S404A.

MP62-18: New Findings Regarding Independent Predictors of Poor Corporal Integrity in a Large Series of Penile Implant Recipients: A Multicenter International Investigation. Chrystal Chang*, Fox Chase Cancer Center; Zafardjan Dalimov, Einstein Healthcare Network; David Barham, UCI Medical Center; Daniel Swerdloff, Einstein Medical Center; Hossein Sadeghi-Nejad, Hackensack University Medical Center; Robert Andrianne, Liege University Hospital; Mike Hsieh, UC San Diego School of Medicine; Martin Gross, Dartmouth-Hitchcock Medical Center; Georgios Hatzichristodolou, Maxime Sempels, Daniar Osmonov, Aaron Lentz, Duke Raleigh Hospital; Paul Perito, Perito Urology; James Hotaling, University of Utah Health; Koenraad Van Renterghem, Sung Hun Park, Seoul, South Korea; Jonathan N. Warner, City of Hope; Faysal A. Yafi, UC Irvine Health; Jay Simhan, MD, FACS, Vice Chair, Department of Urology, Director of Reconstruction and Prosthetics, Fox Chase Cancer Center, Sunday, April 30, 2023 1-3 p.m. CST. Location: S404C.

MP60-15: Favorable Perioperative and Functional Outcomes After Robotic-Assisted Bladder Diverticulectomy. Rohit Reddy*, Temple University Hospital; Brandon Merkert, Naveen Krishnan, Northwestern Medicine; Daniel Eun, MD, Lewis Katz School of Medicine at Temple University; Sunday, April 30, 2023, 1-3 p.m. CST; Location: S401A.

GU Robotic Reconstruction
Sunday, April 30, 2023, 4:30 PM – 5:30 PM CST, Location: Marriott Marquis Chicago-Grand Horizon Ballroom A
Moderator(s) Daniel Eun, MD, Professor of Urology, Lewis Katz School of Medicine at Temple University
Panelist(s) Jill C. Buckley, MD, FACS, University of California, San Diego Michael D. Stifelman, MD, Lee Cheng Zhao, MD, New York University School of Medicine Presenter(s) Sammy E. Elsamra, MD, FACS, Associate Professor of Urology, Rutgers Robert Wood Johnson Medical School & Rutgers Cancer Institute of New Jersey Ziho Lee, MD, MD Northwestern University Nabeel Shakir

Second Opinion Cases: Challenging Scenarios: Irritative Urinary Symptoms in Men
Sunday, April 30, 2023 1:35 PM – 1:55 PM CST Location: Hall B1
Moderator(s) Lenaine Westney, MD, Professor, MD Anderson Cancer Center
Panelist(s) Joshua A. Cohn, MD, FPMRS, Assistant Professor of Urology, Fox Chase Cancer Center/Temple Health Melissa Rae Kaufman, MD, PHD, FACS, Professor, Vanderbilt Medical Center Jaspreet Singh Sandhu, MD, Memorial Sloan Kettering Cancer Center Brian J. Flynn, MD, Professor of Surgery/Urology, University of Colorado Anschutz Medical Campus

Monday, May 1

PD42-09: Intracavernosal Injection History is Associated with Increased Intra- and Postoperative Inflatable Penile Prosthesis Complications: A Multi-institutional Analysis; James Jones*, Einstein Healthcare Network; Martin Gross, Dartmouth-Hitchcock Health Care System; David Barham, UCI Medical Center; Muhammed Hammad, UCI Department of Urology; Daniel Swerdloff, Einstein Healthcare Network; Jake Miller, UC Irvine Department of Urology; Robert Andrianne, Liege; Arthur Burnett, Kelli Gross, Georgios Hatzichristodoulou, Nuremburg, Germany; James Hotaling, Chin Hsieh, Adam Jones, Manchester, United Kingdom; Aaron Lentz, Jason Levy, Vaibhav Modgil, Manchester, United Kingdom; Daniar Osmonov, Kiel, Germany; Sung Hun Park, Seoul, Republic of Korea; Ian Pierce, Manchester, United Kingdom; Paul Perito, Coral Gables, FL; Hossein Sadeghi-Nejad, Newark, NJ; Maxime Sempels, Liege, Belgium; Alfredo Suarez-Sarmiento Jr., Coral Gables, FL; Jay Simhan, MD, FACS, Vice Chair, Department of Urology, Director of Reconstruction and Prosthetics, Fox Chase Cancer Center; Koenraad van Renterghem, Hasselt, Belgium; J. Nicholas Warner, Matthew Ziegelmann, Rochester, MN; Faysal Yafi, Orange, CA; Monday, May 1, 2023 10:50 AM – 11:00 AM CST; Location: S401C.

081IC - Renal Mass and Localized Renal Cancer: Evaluation, Management and Follow-up: A Case-Based Approach, Monday, May 1, 2023 10:00 AM – 12:00 PM CST Location: S103C Instructional Course Director(s) Steven Charles Campbell, MD, PHD, Cleveland Clinic Instructional Course Faculty(s) Ithaar H. Derweesh, MD, Professor of Urology and Radiology, University of California San Diego School of Medicine Robert G. Uzzo, MD, MBA, FACS, President and CEO, Fox Chase Cancer Center, Fox Chase Cancer Center - Temple University Health System Christopher John Weight, MD, MS, Center Director Urologic Oncology, Cleveland Clinic

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427